Fluorescence imaging studies for the disposition of daunorubicin liposomes (DaunoXome) within tumor tissue

Cancer Research

Volumn 56, Issue 9, 1996, Pages 2066-2075

  Forssen, E A ^a   Male Brune R ^a   Adler Moore, J P ^a   Lee, M J A ^a   Schmidt, P G ^a   Krasieva, T B ^b   Shimizu, S ^b   Tromberg, B J ^b  

^a NeXstar Pharmaceuticals Inc   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAUNORUBICIN;

ANIMAL CELL; ARTICLE; CANCER CHEMOTHERAPY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG TRANSPORT; DRUG UPTAKE; FEMALE; FLUORESCENCE; LYMPHOSARCOMA; MOUSE; NONHUMAN; PHARMACEUTICS; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

ANIMALS; CELL SURVIVAL; DAUNORUBICIN; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; FEMALE; LIPOSOMES; LYMPHOMA, DIFFUSE; MICE; MICE, INBRED BALB C; MICROSCOPY, FLUORESCENCE; TUMOR CELLS, CULTURED;

EID: 0029875698     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Allen T M., Hansen C, B., and Guo L. S. Subcutaneous administration of liposomes: a comparison with the intravenous and intraperitoneal routes of injection. Biochim Biophys. Acta, 1150 9-16, 1993.
2. Turner, A F , Presant, C. A., Proffitt, R. T., Williams, L. E., Winsor, D W., and Werner, J L. In-111-labeled liposomes: dosimetry and tumor depiction. Radiology, 166: 761-765, 1988
3. Forssen, E A , Coulter, D M , and Proffitt, R. T. Selective in vivo localization of daunorabicin small unilamellar vesicles in solid tumors. Cancer Res., 52, 3255-3261, 1992
4. Proffitt, R. T , Williams, L. E., Presant, C, A., Tin, G. W. Uliana, J. A., Gamble, R. C., and Baldeschwieler, J. D. Tumor-imaging potential of liposomes loaded with In-111-NTA: biodistribution in mice. J. Nucl Med , 24: 45-51, 1983
5. Proffitt, R. T., Williams, L E., Presant, C. A., Tin, G. W., Uliana, J A , Gamble, R. C., and Baldeschwieler, J. D. Liposomal blockage of the reticuloendothelial system: improved tumor imaging with small unilamellar vesicles. Science (Washington DC), 220: 502-505, 1983.
6. Williams, L E, Proffitt, R. T , and Lovisatti, L. Possible applications of phospholipid vesicles (liposomes) in diagnostic radiology. J Nucl. Med. Allied Sci , 28: 35-45, 1984
7. Kubo, A , Nakamura, K., Sammiya, T , Katayama, M., Hashimoto, T., Hashimoto, S., Kobayashi, H., and Teramoto, T. Indium-111-labelled liposomes: dosimetry and tumour detection in patients with cancer. Eur. J Nucl Med., 20: 107-113, 1993.
8. Presant, C. A., Blayney, D., Proffitt, R. T., Turner, A F., Williams, L. E., Nadel, H. I., Kennedy, P., Wiseman, C., Gala, K , Crossley, R. J., Preiss, S. J., Ksionski, G. E., and Presant, S. L. Preliminary report: Kaposi sarcoma and lymphoma in AIDS with indium-111-labeled liposomes. Lancet, 335: 1307-1309, 1990.
9. Presant, C. A., Proffitt, R T , Turner, A. F., Williams, L. E., Winsor, D., Werner, J L , Kennedy, P., Wisemand, C., Gala, K., McKenna, R. J., Smith, J. D., Bouzaglou, S A., Callahan, R. A., Baldeschwieler, J. D., and Crossley, R. J. Successful imaging of human cancer with indium-111-labeled phospholipid vesicles. Cancer (Phila.), 62: 905-911, 1988
10. Forssen, E. A., and Ross, M E. DaunoXome treatment of solid tumors. Preclinical and clinical investigations. J. Liposome Res., 4: 481-512, 1994.
11. Presant, C. A., Scolaro, M., Kennedy, P., Blayney, D. W , Flanagan, B., Lisak, J., and Presant, J. Liposomal daunorubicin treatment of HIV-associated Kaposi's sarcoma. Lancet, 341: 1242-1243, 1993.
12. Gill, P. S., Espina, B. M., Muggia, F., Cabriales, S., Tupule, A., Esplin, J. A., Liebman, H. A , Forssen, E. A., Ross, M. E., and Levine, A. M. Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin. J. Clin. Oncol., 13: 996-1003, 1995.
13. Schurmann, D., Dormann, A., Grunewald, T., and Ruf, B. Successful treatment of AIDS-related pulmonary Kaposi's sarcoma with liposomal daunorubicin Eur Respir. J., 7, 824-825, 1994
14. Money-Kyrle, J. F., Bates, F., Ready, L. Gazzard, B G. Phillips, R. H , and Boag, F. C. Liposomal daunorubicin in advanced Kaposi's sarcoma: a phase II study. Clin. Oncol. (R. Coll. Radiol.). 5: 367-371, 1993.
15. Eckardt, J. R., Campbell, E., Burns, H. A., Weiss, G. R., Rodriguez, G. I., Fields, S. M., Thurman, A. M., Peacock, N. W., Cobb, P., Rothenberg, M. L., Ross, M. E , and Von Hoff, D. D. A Phase II trial of DaunoXome, liposome-encapsulated daunorubicin, in patients with metastatic adenocarcinoma of the colon. Am. J. Clin. Oncol., 17: 498-501, 1994.
16. Schwartz, H. S. A fluorometric assay for daunomycin and adriamycin in animal tissues. Biochem. Med., 7. 396-404, 1973.
17. Finkel, J. M., Knapp, K. T., and Mulligan, L. T. Fluorometric determination of serum levels and urinary excretion of daunomycin (NSC-82151) in mice and rats. Cancer Chemother. Rep., 53: 159-164, 1969.
18. Gibaldi, M., and Perner, D. In: J. Swarbrick (ed.), Pharmacokinetics - Drugs and the Pharmaceutical Sciences, Vol. 1, Chapter 4, pp. 129-174. New York: Marcel Dekker, Inc , 1975
19. Forssen, E. A. Chemotherapy with anthracycline-liposomes. In: G. Gregoriadis (ed.). Liposomes as Drug Carriers: Recent Trends and Progress, pp. 355-364. Chichester, united Kingdom: John Wiley & Sons Ltd., 1988.